Just Pick the Day. And We’ll Help You Save It.
BOOTH #1137 | New Orleans, LA
Let’s meet @ASGCT and explore together if strengths like these from Viralgen can help you conquer your project:
.svg "text (2)")
Forecast your serotype’s performance from our 1,500+ AAV runs
Leverage Pro10™, our AAV platofrm designed for best-in-class speed to scale
.svg "text (1)")
Partner with our team of experts that has 100% success rate in IND/IMPD dossier submissions
Schedule A Meeting
Fresh research on AAV manufacturing
Stop by Poster Hall 12 throughout the week for a quintet of research updates from the scientific and technology leads at Viralgen who are helping shape the future of AAV-based gene therapy manufacturing.
Streamlining Advanced Therapy Medicinal Product Manufacturing: A Platform Approach for Accelerating Gene Therapy Commercialization at Viralgen
Presented by Cesar Trigueros
May 15, 5:30-7pm CT
Poster Hall I2
Poster # AMA988
Benefits of High-Throughput Sequencing-Based Methods for In-Depth Characterization of Recombinant AAV Products
Presented by Sonia Stinus
May 14, 5:30-7pm CT
Poster Hall I2
Poster # AMA905
Enhancing the Upstream Performance of Adeno-Associated Virus (AAV) Vector Manufacturing via Multivariate Data Analysis
Presented by Ainara Apezteguia
May 15, 5:30-7pm CT
Poster Hall I2
Poster # AMA1624
Leveraging Historical Data and Percentile based Modeling for Improved AAV Production Scaling
Presented by Itsasne Arangoa
May 15, 5:30-7pm CT
Poster Hall I2
Poster # AMA1546
Integrating Raman Spectroscopy and Genome-Scale Modeling to Enhance AAV Upstream Manufacturing
Presented by Itsasne Arangoa
May 13, 6-7:30pm CT
Poster Hall I2
Poster # AMA1539
Tools & Technology Forum
Presented by María Iglesias
Head of IT & Digital, Viralgen
A Rock in a Storm: Using Data as Your Foundation to Speed and De-risk AAV Manufacturing
Friday, May 16, 1:30pm, Exhibit Theater
Let’s Connect
Bayer fully supports coordinated vulnerability disclosure and encourages security researchers who choose to engage in these actions to do so in a responsible manner.
Coordinated Vulnerability Disclosure Statement
